{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:12:44Z","timestamp":1788721964046,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012521"],"award-info":[{"award-number":["2023A1515012521"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20231079"],"award-info":[{"award-number":["20231079"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500739"],"award-info":[{"award-number":["81500739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202103000050"],"award-info":[{"award-number":["202103000050"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29984","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T23:19:35Z","timestamp":1713655175000},"page":"e29984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel artemisinin derivative P31 inhibits VEGF-induced corneal neovascularization through AKT and ERK1\/2 pathways"],"prefix":"10.1016","volume":"10","author":[{"given":"Wen","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063111","article-title":"Ocular surface infection mediated molecular stress responses: a review [J]","volume":"23","author":"Das","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29984_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101090","article-title":"Corneal stromal repair and regeneration [J]","volume":"91","author":"Mohan","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e29984_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115084","article-title":"Up-to-date molecular medicine strategies for management of ocular surface neovascularization [J]","volume":"201","author":"Yang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2024.e29984_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ebiom.2019.05.026","article-title":"Three kinds of corneal host cells contribute differently to corneal neovascularization [J]","volume":"44","author":"Yu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e29984_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond [J]","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Ferrara. Targeting angiogenesis in oncology, ophthalmology and beyond [J]","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"Ferrara. VEGF in signaling and disease: beyond discovery and development [J]","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29984_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.tips.2016.10.003","article-title":"Therapeutics targeting FGF signaling network in human diseases [J]","volume":"37","author":"Katoh","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling [J]","volume":"122","author":"Felcht","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29984_bib10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ymthe.2017.04.020","article-title":"Hepatocyte growth factor suppresses inflammation and promotes epithelium repair in corneal injury [J]","volume":"25","author":"Omoto","year":"2017","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29984_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139202","article-title":"HIF-1\u03b1 and HIF-2\u03b1 redundantly promote retinal neovascularization in patients with ischemic retinal disease [J]","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e29984_bib12","article-title":"Melatonin maintains inner blood-retinal barrier by regulating microglia via inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB signaling pathways in experimental diabetic retinopathy [J]","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29984_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer [J]","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e29984_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Cousins. Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities [J]","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e29984_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin [J]","volume":"216","author":"Ma","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e29984_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107284","article-title":"Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition [J]","volume":"91","author":"Huai","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e29984_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107650","article-title":"Traditional application and modern pharmacological research of Artemisia annua L [J]","volume":"216","author":"Feng","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e29984_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy [J]","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib19","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201867R","article-title":"Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis [J]","volume":"37","author":"Liu","year":"2023","journal-title":"Faseb. J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29984_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug [J]","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29984_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109181","article-title":"Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea [J]","volume":"117","author":"Yuan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e29984_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2782429","article-title":"Artemisinin and its derivate alleviate pulmonary hypertension and vasoconstriction in rodent models [J]","volume":"2022","author":"Bao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29984_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cbf.2995","article-title":"The effects of artemisinin on the proliferation and apoptosis of vascular smooth muscle cells of rats [J]","volume":"32","author":"Wang","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29984_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/odi.14418","article-title":"Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor [J]","volume":"30","author":"Yu","year":"2024","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29984_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000076256","article-title":"Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR\/flk-1 [J]","volume":"71","author":"Chen","year":"2004","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29984_bib26","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.7150\/ijbs.82855","article-title":"SCF\/c-Kit-activated signaling and angiogenesis require G\u03b1i1 and G\u03b1i3 [J]","volume":"19","author":"Shan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29984_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-023-01410-y","article-title":"Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia [J]","volume":"16","author":"Mo","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29984_bib28","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1096\/fj.201701074RR","article-title":"Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization [J]","volume":"32","author":"Zhang","year":"2018","journal-title":"Faseb. J."},{"issue":"32","key":"10.1016\/j.heliyon.2024.e29984_bib29","doi-asserted-by":"crossref","first-page":"52699","DOI":"10.18632\/oncotarget.17084","article-title":"TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion [J]","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e29984_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer [J]","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29984_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12294","article-title":"TGF\u03b2(+) small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro-angiogenic phenotype [J]","volume":"11","author":"Ludwig","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29984_bib32","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41556-022-01026-3","article-title":"Monocytes deposit migrasomes to promote embryonic angiogenesis [J]","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29984_bib33","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41467-021-22131-1","article-title":"Osteoclasts protect bone blood vessels against senescence through the angiogenin\/plexin-B2 axis [J]","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e29984_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116943","article-title":"Artemisinin attenuates the development of atherosclerotic lesions by the regulation of vascular smooth muscle cell phenotype switching [J]","volume":"237","author":"Du","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e29984_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization [J]","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e29984_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25153468","article-title":"Corson. Pharmacological potential of small molecules for treating corneal neovascularization [J]","volume":"25","author":"Barry","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29984_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2022.03.024","article-title":"Bevacizumab in high-risk corneal transplantation: a pilot multicenter prospective randomized control trial [J]","volume":"129","author":"Dohlman","year":"2022","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29984_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5935\/0004-2749.20140054","article-title":"Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization [J]","volume":"77","author":"Ozdemir","year":"2014","journal-title":"Arq. Bras. Oftalmol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29984_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.21037\/atm-20-4558","article-title":"Artesunate induces apoptosis and inhibits the proliferation, stemness, and tumorigenesis of leukemia [J]","volume":"8","author":"Chen","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e29984_bib40","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.3390\/ijms21218068","article-title":"The effect of artemisinin on inflammation-associated lymphangiogenesis in experimental acute colitis [J]","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.heliyon.2024.e29984_bib41","doi-asserted-by":"crossref","first-page":"33046","DOI":"10.18632\/oncotarget.5422","article-title":"Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis [J]","volume":"6","author":"Jeong","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29984_bib42","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1167\/iovs.12-11068","article-title":"The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells [J]","volume":"54","author":"Cheng","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2024.e29984_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.714646","article-title":"Artesunate suppresses choroidal melanoma vasculogenic mimicry formation and angiogenesis via the wnt\/CaMKII signaling Axis [J]","volume":"11","author":"Geng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29984_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11684-021-0898-6","article-title":"Discovery and repurposing of artemisinin [J]","volume":"16","author":"Shi","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e29984_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115535","article-title":"Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases [J]","volume":"257","author":"Jiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29984_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges [J]","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29984_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.thromres.2014.12.006","article-title":"Elevated circulating VE-cadherin+CD144+endothelial microparticles in ischemic cerebrovascular disease [J]","volume":"135","author":"Li","year":"2015","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29984_bib48","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41388-018-0525-4","article-title":"IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma [J]","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29984_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/cbdd.13529","article-title":"Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization [J]","volume":"95","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29984_bib50","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/or.2016.5030","article-title":"PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K\/Akt signaling pathway by regulating PTEN [J]","volume":"36","author":"Xiong","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29984_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.2018080853","article-title":"Mallipattu. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities [J]","volume":"30","author":"Estrada","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29984_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s43018-022-00353-6","article-title":"Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs [J]","volume":"3","author":"Hongu","year":"2022","journal-title":"Nat Cancer"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:51:10Z","timestamp":1773766270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024060158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024060158"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29984","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel artemisinin derivative P31 inhibits VEGF-induced corneal neovascularization through AKT and ERK1\/2 pathways","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29984"}}